EP0703242 - HUMAN-ORIGIN TUMOR CELL PROLIFERATION INHIBITING FACTOR [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 09.03.2001 Database last updated on 12.07.2024 | Most recent event Tooltip | 25.07.2008 | Change - representative | published on 27.08.2008 [2008/35] | Applicant(s) | For all designated states TAISHO PHARMACEUTICAL CO. LTD 24-1 Takata 3-chome Toshima-ku Tokyo 171 / JP | [N/P] |
Former [1996/13] | For all designated states TAISHO PHARMACEUTICAL CO. LTD 24-1 Takata 3-chome Toshima-ku Tokyo 171 / JP | Inventor(s) | 01 /
KOMURASAKI, Toshi, Taisho Pharmaceutical Co. Ltd. 24-1, Takata 3-chome Toshima-ku Tokyo 171 / JP | 02 /
NAKAZAWA, Kiyoshi, Taisho Pharmaceutical Co. Ltd. 24-1, Takata 3-chome Toshima-ku Tokyo 171 / JP | 03 /
TOYODA, Hitoshi, Taisho Pharmaceutical Co. Ltd. 24-1, Takata 3-chome Toshima-ku Tokyo 171 / JP | 04 /
TAKAHASHI, Masayoshi, Taisho Pharmaceutical Co Ltd 24-1, Takata 3-chome Toshima-ku Tokyo 171 / JP | 05 /
UCHIDA, Daisuke, Taisho Pharmaceutical Co. Ltd. 24-1, Takata 3-chome Toshima-ku Tokyo 171 / JP | 06 /
HANADA, Kazunori, Taisho Pharmaceutical Co. Ltd. 24-1, Takata 3-chome Toshima-ku Tokyo 171 / JP | 07 /
UDAKA, Shigezo 24-3, Uesonocho 1-chome Meito-ku Nagoya-shi, Aichi 465 / JP | [1996/13] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
Former [1996/13] | VOSSIUS & PARTNER Siebertstrasse 4 D-81675 München / DE | Application number, filing date | 94917147.4 | 02.06.1994 | [1996/13] | WO1994JP00895 | Priority number, date | JP19930134854 | 04.06.1993 Original published format: JP 13485493 | JP19930134855 | 04.06.1993 Original published format: JP 13485593 | [1996/13] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9429340 | Date: | 22.12.1994 | Language: | EN | [1994/28] | Type: | A1 Application with search report | No.: | EP0703242 | Date: | 27.03.1996 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.12.1994 takes the place of the publication of the European patent application. | [1996/13] | Search report(s) | International search report - published on: | JP | 22.12.1994 | Classification | IPC: | C07K7/10, C12N15/12, C12N1/21, C12P21/02, // C12N1:21, C12R1:08, C12P21:02, C12R1:08 | [1996/13] | CPC: |
C07K14/4703 (EP,US);
C07K14/475 (KR);
C07K14/47 (EP,US);
C07K14/52 (EP,US);
C12N15/11 (KR);
C12P21/02 (KR);
A61K38/00 (EP,US)
(-)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1996/13] | Title | German: | INHIBIERENDER FAKTOR DER PROLIFERATION VON TUMORZELLEN MENSCHLICHER HERKUNFT | [1996/13] | English: | HUMAN-ORIGIN TUMOR CELL PROLIFERATION INHIBITING FACTOR | [1996/13] | French: | FACTEUR D'INHIBITION DE LA PROLIFERATION DE CELLULES TUMORALES D'ORIGINE HUMAINE | [1996/13] | Entry into regional phase | 02.01.1996 | Translation filed | 02.01.1996 | National basic fee paid | 02.01.1996 | Search fee paid | 02.01.1996 | Designation fee(s) paid | 02.01.1996 | Examination fee paid | Examination procedure | 20.09.1994 | Request for preliminary examination filed International Preliminary Examining Authority: JP | 02.01.1996 | Examination requested [1996/13] | 02.03.2001 | Application withdrawn by applicant [2001/17] | Fees paid | Renewal fee | 02.01.1996 | Renewal fee patent year 03 | 27.06.1997 | Renewal fee patent year 04 | 29.06.1998 | Renewal fee patent year 05 | 29.06.1999 | Renewal fee patent year 06 | 28.06.2000 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]JPH04211698 (TAISHO PHARMACEUTICAL CO LTD ); | [XP]WO9311233 (TAISHO PHARMACEUTICAL CO LTD [JP]) |